RHINOMED RELEASES MUTE SLEEP TECHNOLOGY
8 December 2014
Melbourne bio-technology firm, Rhinomed (ASX:RNO) is pleased to announce the release of its newest device from it nasal respiratory technology stable of products, Mute™, a nasal breathing aid to alleviate snoring and improve sleep quality.
Mute™ was successfully registered last week with the US FDA, Australian TGA and given permission to use the CE Mark from the European authority. As a result Rhinomed has fast tracked the online release of the technology, which can now be purchased directly from the company at www.mutesnoring.com.